In progress
Click on the tabs for more information about the status of each phase in the review process. For more information about how each phase is conducted, please read about the reconsideration process.
Work plan
Work plan
Click on the tabs for more information about the status of each phase in the review process. For more information about how each phase is conducted, please read about the reconsideration process.
Chemicals
- Diazinon
Review period
Timeframe calculation pursuant to Regulation 85 of the Agricultural and Veterinary Chemicals Code Regulations 1995A + B + 2E + 3C + J + D + X = 37 months
A = 13 months (Environment – level 1)
B = 8 months (Residues – level 2, OH&S – level 2*, Non-food trade)
C = 3 months (Finalisation – type 1)
D = 4 months
E = 0 months
J = 3 months (consultation with jurisdictional coordinator)
X = 0 months (in any other case)
*pre-December 2022 module descriptions
1. Nomination
1. Nomination
Phase status
CompletedDiazinon active constituents, chemical products and labels were nominated for review in response to an invitation to the public by the APVMA (then the NRA) on 1 November 1994. Eighty of the nominated chemicals, including diazinon, were included in the priority candidate review list published in the Gazette on 2 May 1995.
2. Prioritisation
2. Prioritisation
Phase status
Completed
3. Scoping and work plan
3. Scoping and work plan
Phase status
CompletedThe scope of the review includes reconsideration of diazinon active constituents, chemical products and labels through assessments related to toxicology, work health and safety, chemistry, residues and environment.
The work plan was first published on 1 July 2015.
4. Notice of reconsideration
4. Notice of reconsideration
Phase status
CompletedThe s 32 notice of reconsideration for active constituents, chemical products and labels for diazinon was published in the Gazette on 3 December 1996.
The s 32 notice of reconsideration was given to holders and chemical coordinators of the states and territories on commencement of the review on 5 July 1996.
Additional s 32 notices were sent to holders on 1 July 2015, 11 April 2019, 20 June 2022 and 1 December 2022 to include all approved actives and registered products in the review.
Additional s 33 notices were sent to holders on 5 April 2022, 20 June 2022, 16 December 2022 and 21 April 2023 to request additional technical data.
5. Assessment
5. Assessment
Phase status
In ProgressIn 2000 the APVMA (then the NRA) released the diazinon draft report.
In 2002 the APVMA released the revised diazinon draft report and component assessment reports for residues, chemistry, agriculture, toxicology, occupational health and safety, and the environment.
In 2003 the APVMA released the review findings report for diazinon, part 1.
In June 2006, the APVMA released the diazinon preliminary findings review report part 2, volume 1 and volume 2.
In 2011 the APVMA released the toxicology (hazard) component of the diazinon consolidated human health risk assessment.
When all the component risk assessments have been completed, the proposed regulatory decisions will be drafted.
6. Proposed regulatory decision
6. Proposed regulatory decision
Phase status
ForecastedIn 2000, the APVMA released the diazinon draft report.
In 2002, the APVMA released the revised diazinon draft report summary.
In 2003, the APVMA released the diazinon review findings report, part 1, which outlined the proposed regulatory approach.
In June 2006, the APVMA released the diazinon preliminary findings review report part 2, volume 1 and volume 2.
Publication of the proposed regulatory decision is expected in November 2023.
7. Consultation
7. Consultation
Phase status
ForecastedPublic consultations have been conducted following the publication of the diazinon draft report in 2000, the publication of the diazinon revised draft report in 2002, and the publication of the preliminary review findings, part 2 in 2006.
The legislated timeframe for consultation following publication of the proposed regulatory decision is 3 months.
8. Final regulatory decision
8. Final regulatory decision
Phase status
ForecastedIn April 2003, the decision to suspend certain product registrations and cancel other diazinon registrations was made. Holders were notified of the cancellation decision on 15 April 2003 and the decision was published in the Gazette on 6 May 2003.
Following the close of the public consultation period on the proposed regulatory decision, and consideration of submissions received, the final regulatory decision will be published.
Publication of the final regulatory decision is expected in April 2024.
9. Implementation
9. Implementation
Phase status
ForecastedThe implementation period will begin on the date the final regulatory decision is made.